Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients - Concepedia

Concepedia

Publication | Closed Access

Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients

44

Citations

23

References

2018

Year

Corentin Richard, Jean-David Fumet, Sandy Chevrier, Valentin Dérangère, Fanny Ledys, Aurélie Lagrange, Laure Favier, Bruno Coudert, Laurent Arnould, Caroline Truntzer,

Clinical Cancer Research

Abstract

Altogether, these data provide a validated biomarker that predicts the efficacy of nivolumab or pembrolizumab in patients with NSCLC. Our biomarker seems to be superior to PD-L1 labeling and TMB models.

References

	Year	Citations

Page 1